Literature DB >> 21796367

Co-expression of SNAIL and TWIST determines prognosis in estrogen receptor-positive early breast cancer patients.

Johanna G H van Nes1, Esther M de Kruijf, Hein Putter, Dana Faratian, Alison Munro, Fiona Campbell, Vincent T H B M Smit, Gerrit-Jan Liefers, Peter J K Kuppen, Cornelis J H van de Velde, John M S Bartlett.   

Abstract

Epithelial mesenchymal transition (EMT) plays an important role in the development of metastases. One of the hallmarks of EMT is loss of E-cadherin and gain of N-cadherin expression, which are regulated by transcription factors, such as SNAIL, SLUG, and TWIST. We examined the prognostic value of these factors as well as E-cadherin and N-cadherin, in a well-described large cohort of breast cancer patients treated with primary surgery. Analyses were stratified by estrogen receptor (ER) status, because of its crucial role in the regulation of these transcription factors. SNAIL, SLUG, and TWIST expression were examined on a TMA containing 575 breast tumors using immunohistochemistry. Nuclear expression was quantified using a weighted histoscore and classified as high versus low expression, based on the median histoscore. High expression of SNAIL, SLUG, and TWIST was seen in 54, 50, and 50% of tumors, respectively. The level of SNAIL (P = 0.014) and TWIST (P = 0.006) expression was associated with a worse patient relapse-free period, specifically in patients with ER-positive tumors (interaction Cox proportional hazards P = 0.039). Combining both factors resulted in an independent prognostic factor with high discriminative power (both low versus either high: HR 1.15; both low versus both high HR 1.84; P = 0.010). Co-expression of SNAIL-TWIST was associated with low-E-cadherin and high-N-cadherin expression, especially in ER-positive tumors (P = 0.009), suggesting that, through interactions with ER, SNAIL and TWIST may regulate E- and N-cadherin expression, thereby inducing EMT. Our results are indicative that SNAIL and TWIST play a crucial role in EMT through regulation of E- and N-cadherin expression, exclusively in ER-positive breast cancer patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21796367     DOI: 10.1007/s10549-011-1684-y

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  40 in total

1.  Inflammatory factors of the tumor microenvironment induce plasticity in nontransformed breast epithelial cells: EMT, invasion, and collapse of normally organized breast textures.

Authors:  Tal Leibovich-Rivkin; Yulia Liubomirski; Biana Bernstein; Tsipi Meshel; Adit Ben-Baruch
Journal:  Neoplasia       Date:  2013-12       Impact factor: 5.715

2.  Combined Runx2 and Snail overexpression is associated with a poor prognosis in breast cancer.

Authors:  Zhengjun Yang; Bin Zhang; Bowen Liu; Yegong Xie; Xuchen Cao
Journal:  Tumour Biol       Date:  2015-01-22

3.  RhoC upregulation is correlated with reduced E-cadherin in human breast cancer specimens after chemotherapy and in human breast cancer MCF-7 cells.

Authors:  Hirotoshi Kawata; Tomoko Kamiakito; Yawara Omoto; Chieko Miyazaki; Yasuo Hozumi; Akira Tanaka
Journal:  Horm Cancer       Date:  2014-08-15       Impact factor: 3.869

4.  IL-1β promotes proliferation and migration of gallbladder cancer cells via Twist activation.

Authors:  Runsheng Guo; Yiyu Qin; Peidong Shi; Jinbi Xie; Ming Chou; Yueyu Chen
Journal:  Oncol Lett       Date:  2016-10-13       Impact factor: 2.967

5.  Expression of TWIST1, Snail, Slug, and NF-κB and methylation of the TWIST1 promoter in mammary phyllodes tumor.

Authors:  Sung-Im Do; Ji Yeon Kim; So Young Kang; Jae Joon Lee; Jeong Eon Lee; Seok Jin Nam; Eun Yoon Cho
Journal:  Tumour Biol       Date:  2012-11-14

6.  Strong correlation between N-cadherin and CD133 in breast cancer: role of both markers in metastatic events.

Authors:  Carolin Bock; Christina Kuhn; Nina Ditsch; Regina Krebold; Sabine Heublein; Doris Mayr; Sophie Doisneau-Sixou; Udo Jeschke
Journal:  J Cancer Res Clin Oncol       Date:  2014-06-25       Impact factor: 4.553

7.  On the origin and destination of cancer stem cells: a conceptual evaluation.

Authors:  Anja van de Stolpe
Journal:  Am J Cancer Res       Date:  2013-01-18       Impact factor: 6.166

8.  Expression and significance of c-kit and epithelial-mesenchymal transition (EMT) molecules in thymic epithelial tumors (TETs).

Authors:  Zhigang Wu; Songtao Xue; Bin Zheng; Rongjin Ye; Guobing Xu; Shuliang Zhang; Taidui Zeng; Wei Zheng; Chun Chen
Journal:  J Thorac Dis       Date:  2019-11       Impact factor: 2.895

9.  Mutant p53 and Twist1 Co-Expression Predicts Poor Prognosis and Is an Independent Prognostic Factor in Breast Cancer.

Authors:  Yong-Qu Zhang; Fan Zhang; Yun-Zhu Zeng; Min Chen; Wen-He Huang; Jun-Dong Wu; Wei-Ling Chen; Wen-Liang Gao; Jing-Wen Bai; Rui-Qin Yang; Huan-Cheng Zeng; Xiao-Long Wei; Guo-Jun Zhang
Journal:  Front Oncol       Date:  2021-06-24       Impact factor: 6.244

10.  Pathways to breast cancer recurrence.

Authors:  Aamir Ahmad
Journal:  ISRN Oncol       Date:  2013-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.